340B Drug Pricing Program Reporting

Beginning in April 2024, health care entities that participate as “covered entities” in the federal 340B Drug Pricing Program will be required to annually report data related to their 340B prescription drug purchases and payments to the Minnesota Department of Health (MDH). MDH will synthesize its findings in annual reports to the legislature on the reported data beginning in November 2024. 

This initiative was established by the legislature in 2023, updated during the 2024 session, and is codified in Minnesota Statues, section 62J.312, subd. 6. 

This website serves as a means monitor progress, access resources, ask questions, and sign up for our email updates for news and notifications. 

NEW: MDH announced upcoming implementation steps and timeline for year two reporting due April 1, 2025.

Register and Report Online

Reporting entities preparing to submit a report are encouraged to access the online reporting system to register at MN Department of Health Rx. Data submitters may view the Registration Quick-Start Guide (PDF), consult the Registration and Account Management Guide (PDF), or visit the Data Reporting Portal Help page for more resources. 

Reporting Resources

• Form and Manner for 340B Covered Entities (PDF)
• Frequently Asked Questions (PDF)
• Rx Data Reporting Portal
• Tutorial: Online Portal for 340B Reporting (YouTube)

For other instructional videos and user guides for the online reporting systems at the Rx Data Portal, please view MDH's Rx Data Reporting Help page. 

Upcoming Implementation Steps 

• By November 2024: MDH releases first report to the Legislature on the 340B Covered Entity Reporting
• Fall 2024: MDH releases revised reporting guidance resulting from 2024 legislative changes for public comment
• Early 2025: MDH releases finalized reporting guidance, reporting resources, and updated reporting functionality on the online reporting system for 2025 reporting
• April 1, 2025: Covered entities’ reports are due to MDH